These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 17354215)

  • 21. BIO 2006 Annual International Convention. Innovations in biotech in China and Italy.
    Tear S; Zarkowska T
    IDrugs; 2006 Jun; 9(6):386-9. PubMed ID: 16752303
    [No Abstract]   [Full Text] [Related]  

  • 22. Biotech firms jump on SARS bandwagon.
    Basu P
    Nat Biotechnol; 2003 Jul; 21(7):720. PubMed ID: 12833076
    [No Abstract]   [Full Text] [Related]  

  • 23. Can China's supply of scientific talent keep up with demand?
    Wong G
    Nat Biotechnol; 2008 Feb; 26(2):243-4. PubMed ID: 18259182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UK industry consolidation is slow despite big merger.
    Mitchell P
    Nat Biotechnol; 2003 Mar; 21(3):215. PubMed ID: 12610553
    [No Abstract]   [Full Text] [Related]  

  • 25. Roche vows to keep Genentech culture.
    Hayden EC
    Nature; 2009 Mar; 458(7236):270. PubMed ID: 19295574
    [No Abstract]   [Full Text] [Related]  

  • 26. BIOCENTURY, outrunner of China's biological technology in agriculture Biocentury Transgene (China) Co., Ltd.
    Cui H; Huang T
    Biotechnol J; 2006 Nov; 1(11):1203-4. PubMed ID: 17109490
    [No Abstract]   [Full Text] [Related]  

  • 27. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 28. Going it alone.
    Senior M
    Nat Biotechnol; 2014 May; 32(5):411-4. PubMed ID: 24811507
    [No Abstract]   [Full Text] [Related]  

  • 29. From the analyst's couch: The outlook for biotech exits.
    Grimaldi A
    Nat Biotechnol; 2014 Mar; 32(3):227-8. PubMed ID: 24727772
    [No Abstract]   [Full Text] [Related]  

  • 30. Perspectives on high technologies for low-cost healthcare.
    Poon CC; Zhang YT
    IEEE Eng Med Biol Mag; 2008; 27(5):42-7. PubMed ID: 18799389
    [No Abstract]   [Full Text] [Related]  

  • 31. Genzyme and Isis strike megadeal.
    Mack GS
    Nat Biotechnol; 2008 Mar; 26(3):251-3. PubMed ID: 18327216
    [No Abstract]   [Full Text] [Related]  

  • 32. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antisoma-Roche deal--a new kind of buyout?
    Mitchell P
    Nat Biotechnol; 2003 Jan; 21(1):3. PubMed ID: 12511894
    [No Abstract]   [Full Text] [Related]  

  • 34. Biotechnology in the Medicon Valley.
    Frank L
    Nature; 2002 Dec; 420(6916 Suppl):A27, A29, A31 passim. PubMed ID: 12501124
    [No Abstract]   [Full Text] [Related]  

  • 35. 25 top health care stocks. Will they lead the next market boom?
    Kane L
    Med Econ; 2001 Apr; 78(7):126-8, 133-6, 140-2. PubMed ID: 11368040
    [No Abstract]   [Full Text] [Related]  

  • 36. Private company profiles.
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE23-8. PubMed ID: 12874973
    [No Abstract]   [Full Text] [Related]  

  • 37. What mergers can do for you.
    Acharya A
    Nat Biotechnol; 2011 Jun; 29(6):477-9. PubMed ID: 21796820
    [No Abstract]   [Full Text] [Related]  

  • 38. The production capacity bottleneck.
    De Keyser JL
    Nat Biotechnol; 2001 Aug; 19(8):715. PubMed ID: 11479555
    [No Abstract]   [Full Text] [Related]  

  • 39. Strategic considerations for the biotechnology business to the year 2000.
    Cometta S
    Arzneimittelforschung; 1989 Aug; 39(8):929-34. PubMed ID: 2818683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DPI delivers biotechnology superstore. Discovery Partners International.
    Glaser V
    Nat Biotechnol; 1998 Dec; 16(13):1302. PubMed ID: 9853596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.